Cancer Research Institute (CRI) shared a post on LinkedIn:
“Could CAR T-cell therapy show promise against deadly childhood brain cancer? Marking one of its ‘first successes against solid tumors,’ results published in Springer Nature’s Nature showcase how CAR T-cell therapy shrank children’s brain tumors, restored neurologic function, and for one participant in the Stanford University School of Medicine clinical trial, erased all detectable traces of a brain cancer usually considered incurable.
Dive deeper into the findings of investigators, including CRI Lloyd J. Old Star Dr. Robbie Majzner, and explore their impact.”
More posts featuring Cancer Research Institute.